Weihai Baihe Biology Technological Co Ltd

Weihai Baihe Biology Technological Co Ltd maintains a strong liquidity position, with a current ratio of 5.91, indicating that it has more than five times the current assets to cover its current liabilities. The company's liquidity_fpt (liquidity forward performance tracker) suggests that it is well-positioned to meet short-term obligations without significant strain. However, the risk assessment notes that net cash is negative after subtracting total debt, which could signal potential liquidity constraints in the near term. In terms of profitability, the company's return on equity (ROE) is 7.76%, and its return on assets (ROA) is 6.57%, both of which are strong indicators of efficient use of equity and assets to generate profit. These figures are in line with the industry_config preferred metrics for the Food Processing industry, which emphasize asset efficiency and profitability. The company's gross profit margin is 34.29% (312,387,580 / 910,926,740), and its operating margin is 16.58% (151,011,570 / 910,926,740), both of which are above the cohort median for the industry. The company's revenue is primarily concentrated in a single business segment, as disclosed in its financial snapshot. There is no detailed breakdown of geographic exposure, but the company's operations are likely centered in China, given its listing on the Shanghai Stock Exchange. The lack of geographic diversification could pose a concentration risk, particularly if the Chinese market experiences economic or regulatory shifts. Looking ahead, the company's revenue is expected to grow, supported by a positive outlook for the food processing industry. Analysts have assigned a mean recommendation of 1.50, indicating a strong buy consensus. The mean EPS estimate for the next period is 2.08 CNY, slightly above the last actual EPS of 2.05 CNY, suggesting a modest earnings growth expectation. The company's capital expenditure is negative, indicating that it is generating more cash than it is spending on capital investments, which could be a sign of mature operations or a lack of expansion plans. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is 0.01, indicating a very low level of leverage and a strong equity position. However, the negative net cash position after subtracting total debt is a concern, as it could limit the company's ability to invest in growth opportunities or withstand unexpected financial shocks. The company has not issued any recent dilutive securities, and there is no indication of near-term dilution pressure. Recent events, as reflected in the financial data, show a stable performance with consistent revenue and profit growth. The company's operating cash flow is positive at 186,024,460 CNY, and its free cash flow is 77,937,530 CNY, indicating that it is generating sufficient cash to support operations and potentially fund dividends or share repurchases. The company's financial health appears to be in a stable state, with no major red flags in the latest filings or transcripts.